{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-043808","form_type":"8-K","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2023-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.247341+00:00","generated_at":"2026-06-11T05:41:22.105513+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tivic Health implements 1-for-100 reverse stock split to avoid Nasdaq delisting","bullets":["1-for-100 reverse stock split effective Aug 23, 2023; par value unchanged.","Nasdaq had determined to delist TIVC due to bid price ≤ $0.10 for 10 days; appeal hearing set Sep 21, 2023.","Company expects reverse split to bring bid price above $1.00 and regain compliance.","No fractional shares issued; fractional shares rounded up; percentage ownership unchanged.","Warrants, options, and equity awards proportionally adjusted; CUSIP changes to 888705 209."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-043808","json":"https://secwatch.observer/filing/0000950170-23-043808.json","markdown":"https://secwatch.observer/filing/0000950170-23-043808.md","text":"https://secwatch.observer/filing/0000950170-23-043808.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023043808/0000950170-23-043808-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023043808/tivc-20230821.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T05:41:22.105513+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6053f6f0b3624ad8f6f6940a526de1e6a3432294","claim":"Valion Bio, Inc.: Board approved a 1-for-100 reverse stock split of common stock, effective August 23, 2023, to regain compliance with Nasdaq minimum bid price requirement (effective 2023-08-23).","evidence_excerpt":"The Board of Directors of Tivic Health Systems, Inc., a Delaware corporation (the \"Company\"), has approved a reverse stock split of the Company's issued and outstanding shares of common stock, par value $0.0001 per share (\"Common Stock\"), at a ratio of 1-for-100 (the \"Reverse Split\").","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023043808/0000950170-23-043808-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-08-23"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}